These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8936353)
1. International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease. Wolters EC; Tesselaar HJ J Neurol; 1996 Mar; 243(3):235-40. PubMed ID: 8936353 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group. Wolters EC; Horstink MW; Roos RA; Jansen EN Clin Neurol Neurosurg; 1992; 94(3):205-11. PubMed ID: 1327609 [TBL] [Abstract][Full Text] [Related]
3. Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease. Hutton JT; Morris JL; Bush DF; Smith ME; Liss CL; Reines S Neurology; 1989 Nov; 39(11 Suppl 2):67-72; discussion 72-3. PubMed ID: 2685652 [TBL] [Abstract][Full Text] [Related]
4. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. Ahlskog JE; Muenter MD; McManis PG; Bell GN; Bailey PA Mayo Clin Proc; 1988 Sep; 63(9):876-86. PubMed ID: 3045435 [TBL] [Abstract][Full Text] [Related]
5. Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR). Cedarbaum JM; Silvestri M; Clark M; Toy L; Harts A; Green-Parsons A; McDowell FH J Neural Transm Park Dis Dement Sect; 1990; 2(3):205-13. PubMed ID: 2257060 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa. Hutton JT; Morris JL; Román GC; Imke SC; Elias JW Arch Neurol; 1988 Aug; 45(8):861-4. PubMed ID: 3395259 [TBL] [Abstract][Full Text] [Related]
7. An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group. Bush DF; Liss CL; Morton A Neurology; 1989 Nov; 39(11 Suppl 2):101-4; discussion 105. PubMed ID: 2685646 [TBL] [Abstract][Full Text] [Related]
8. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients. Olanow CW; Nakano K; Nausieda P; Tetrud JA; Manyam B; Last B; Block G; Liss C; Bush D Clin Neuropharmacol; 1991 Jun; 14(3):235-40. PubMed ID: 2070363 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Goetz CG; Tanner CM; Shannon KM; Carroll VS; Klawans HL; Carvey PM; Gilley D Neurology; 1988 Jul; 38(7):1143-6. PubMed ID: 3290706 [TBL] [Abstract][Full Text] [Related]
11. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
12. A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance. Cedarbaum JM; Hoey M; McDowell FH J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):207-12. PubMed ID: 2649640 [TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Feldman RG; Mosbach PA; Kelly MR; Thomas CA; Saint Hilaire MH Neurology; 1989 Nov; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655 [TBL] [Abstract][Full Text] [Related]
14. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]
15. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related]
16. Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease--an open evaluation of efficacy and safety. Bulling MT; Wing LM; Burns RJ Aust N Z J Med; 1991 Aug; 21(4):397-400. PubMed ID: 1953526 [TBL] [Abstract][Full Text] [Related]
17. Trial of Sinemet CR4 in patients with Parkinson's disease. Anderson TJ; Ewer TC; Gilchrist NL; Donaldson IM N Z Med J; 1992 Mar; 105(929):81-2. PubMed ID: 1545941 [TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of Sinemet CR in parkinsonian patients with motor fluctuations. Hutton JT; Morris JL Can J Neurol Sci; 1991 Nov; 18(4):467-71. PubMed ID: 1782612 [TBL] [Abstract][Full Text] [Related]